Prevalence of type 2 diabetes among tribal population of india : a multi-centric cross-sectional study
Copyright © 2024 National Medical Association. Published by Elsevier Inc. All rights reserved..
BACKGROUND: The perception among healthcare workers is that the Indian tribal (indigenous) population are less affected by diabetes. This paper reports the prevalence of type 2 diabetes and its associated factors among tribal populations from six districts across India.
METHODOLOGY: Random blood glucose (RBG) and fasting blood glucose (FBG) were measured for 8486 and 3131 adults, respectively, with a glucose meter. FBG ≥ 126 mg/dL (7.0 mmol/L) and RBG ≥ 200 mg/dL (11.1 mmol/L) were used to diagnose diabetes. In addition, blood pressure, anthropometric (height, weight, waist and hip circumferences), socio-demographic (age, gender, education, type of tribe and type of village) and behavioural data (tobacco smoking, non-smoking tobacco use and alcohol consumption) were collected.
RESULTS: The overall prevalence of type 2 diabetes, based on RBG, was 4.77% (95% CI: 4.33-5.25). The prevalence of type 2 diabetes and prediabetes, based on FBG, was 6.80% (95% CI: 5.95-7.74) and 8.69% (7.72-9.73), respectively. The prevalence of type 2 diabetes was significantly associated with age (p<0.001), smokeless tobacco use (p < 0.05), hypertension (p < 0.001) and obesity (p < 0.01).
CONCLUSION: The prevalence of type 2 diabetes among the Indian tribal population reported in this study is less than the national average of 7.3% for the general population. Hypertension and obesity were the major risk factors. Due to changing behavioural patterns, including dietary behaviour, there is likely to be an increase in the prevalence of hypertension and obesity, which further leads to increased prevalence of type 2 diabetes. Hence, appropriate interventions are to be initiated by the primary healthcare system.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:116 |
|---|---|
| Enthalten in: |
Journal of the National Medical Association - 116(2024), 2 Pt 1 vom: 28. März, Seite 153-164 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Babu, Bontha V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jnma.2024.01.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367812274 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367812274 | ||
| 003 | DE-627 | ||
| 005 | 20240318234148.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240131s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jnma.2024.01.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1334.xml |
| 035 | |a (DE-627)NLM367812274 | ||
| 035 | |a (NLM)38290904 | ||
| 035 | |a (PII)S0027-9684(24)00001-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Babu, Bontha V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prevalence of type 2 diabetes among tribal population of india |b a multi-centric cross-sectional study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2024 | ||
| 500 | |a Date Revised 18.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 National Medical Association. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: The perception among healthcare workers is that the Indian tribal (indigenous) population are less affected by diabetes. This paper reports the prevalence of type 2 diabetes and its associated factors among tribal populations from six districts across India | ||
| 520 | |a METHODOLOGY: Random blood glucose (RBG) and fasting blood glucose (FBG) were measured for 8486 and 3131 adults, respectively, with a glucose meter. FBG ≥ 126 mg/dL (7.0 mmol/L) and RBG ≥ 200 mg/dL (11.1 mmol/L) were used to diagnose diabetes. In addition, blood pressure, anthropometric (height, weight, waist and hip circumferences), socio-demographic (age, gender, education, type of tribe and type of village) and behavioural data (tobacco smoking, non-smoking tobacco use and alcohol consumption) were collected | ||
| 520 | |a RESULTS: The overall prevalence of type 2 diabetes, based on RBG, was 4.77% (95% CI: 4.33-5.25). The prevalence of type 2 diabetes and prediabetes, based on FBG, was 6.80% (95% CI: 5.95-7.74) and 8.69% (7.72-9.73), respectively. The prevalence of type 2 diabetes was significantly associated with age (p<0.001), smokeless tobacco use (p < 0.05), hypertension (p < 0.001) and obesity (p < 0.01) | ||
| 520 | |a CONCLUSION: The prevalence of type 2 diabetes among the Indian tribal population reported in this study is less than the national average of 7.3% for the general population. Hypertension and obesity were the major risk factors. Due to changing behavioural patterns, including dietary behaviour, there is likely to be an increase in the prevalence of hypertension and obesity, which further leads to increased prevalence of type 2 diabetes. Hence, appropriate interventions are to be initiated by the primary healthcare system | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a India | |
| 650 | 4 | |a Indigenous | |
| 650 | 4 | |a Prevalence | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Tribal | |
| 650 | 4 | |a Type 2 diabetes | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Hazarika, Chaya R |e verfasserin |4 aut | |
| 700 | 1 | |a Raina, Sunil K |e verfasserin |4 aut | |
| 700 | 1 | |a Masoodi, Shariq R |e verfasserin |4 aut | |
| 700 | 1 | |a Basappa, Yogish C |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Nihal |e verfasserin |4 aut | |
| 700 | 1 | |a Kerketta, Anna S |e verfasserin |4 aut | |
| 700 | 1 | |a Menon, Nanda Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Jebasingh, Felix K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the National Medical Association |d 1909 |g 116(2024), 2 Pt 1 vom: 28. März, Seite 153-164 |w (DE-627)NLM000042420 |x 1943-4693 |7 nnns |
| 773 | 1 | 8 | |g volume:116 |g year:2024 |g number:2 Pt 1 |g day:28 |g month:03 |g pages:153-164 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jnma.2024.01.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 116 |j 2024 |e 2 Pt 1 |b 28 |c 03 |h 153-164 | ||